NAS10026,630−6.36%S&P7,354−4.36%GOLD$4,054−1.44%BTC$75,513−6.08%VIX28.18+69.66%latest tape · as of 06:01 UTC
The Screen · Industrials · Specialty Industrial Machinery
PHParker Hannifin
PH · a US exchange · USD · Market cap $117.1B · 57,950 employees
Parker-Hannifin Corporation manufactures and sells motion and control technologies and systems for aerospace and defense, in-plant and industrial equipment, transportation, off-highway, energy, and HVAC and refrigeration…
Positioning no disclosures inside 60 days, left as found
Options put/call open interest 1.50, read 2026-11-05
Ethical passes the values gate
Price892.29 USD
Fair value999.97
Ethical score85.1/100
Value readUndervaluedas of 5 Nov 2026
Our investment reviews on this name
2026-10-25Read Distribution961.75-7.2% to today ✓Accumulation gives way to Distribution
2026-10-11Read Accumulation978.33-8.8% to today Markdown gives way to Accumulation
2026-09-06Read Markdown1,000.13-10.8% to today ✓Markup gives way to Markdown with volume flow in agreement
2026-07-30Read Markup987.54-9.6% to today Distribution gives way to Markup after a 12% rise in 4 weeks
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Parker Hannifin holds its Distribution at $892.29. The statistical read favours the sellers, held for 7 days.
As held on the ledger · 2026-11-05
Phase
Distribution · caution
Quantitative state
The statistical read favours the sellers, held for 7 days
Price at the screen
$892.29
Valuation
32.60 trailing · 23.36 forward price to earnings
Values screen
PASS· score 85.1
Beta
1.12
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
31.48%
Below 33%
Interest-bearing debt is just 31.5% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
0.00%
Below 33%
Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit.
Pass
Receivables
11.45%
Below 49%
Money owed to the company is 11.4% of assets, under the 49% limit.
Pass
Revenue purity
0.06%
Below 5%
Only 0.1% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Clears, in Plain English
Parker Hannifin clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 31%, inside the ~33% line, and almost none of its income is interest, so it passes.
Read as at 2026-11-05. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when PH's ethical verdict changes
Today PH passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
What the Numbers Say It Is Worth
The Fair Value Range
Our analysis reads Undervalued vs our fair value, as of 5 Nov 2026: it trades at roughly an 11% discount to our $999.97 fair value, moderate competitive moat, 9.80% revenue growth.
Fair value range in USD, drawn from the 2026-11-05 screen. The gold marker is the market price at the same screen. A 10.8% discount to the base estimate.
Where our models see it going: fair-value estimate $999.97, with a range of $612.00 to $1,149.96, dated to the 2026-11-05 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Precision Engineering in a High-Tech World
Imagine the intricate dance of robotics and machinery, where Parker Hannifin provides the choreography. This company manufactures motion and control technologies, a vital backbone for industries ranging from aerospace to energy. Its products enable the smooth operation of complex systems, which is why it stands out. With a forward P/E of 25.3x, robust revenue growth of 10%, and a healthy profit margin of 17%, Parker Hannifin is performing well, but our fair value and the current market price align at approximately $1000, indicating the market is pricing it correctly.
However, despite these positive financials, the stock is rated as OVERVALUED, suggesting that the current price may already reflect future optimism. This valuation is backed by a moderate moat, indicating that while Parker Hannifin has some competitive advantages, they may not be insurmountable. The consensus among 23 analysts is a buy, with a median target price of $1214, but this target could be ambitious given our assessment.
Risks for Parker Hannifin include the cyclical nature of its industrial markets and the potential for economic downturns to impact demand. Additionally, a MODERATE ethical pass reflects that while the company meets our standards, there may be room for improvement. This analysis should be considered in the context of the company's performance and the broader market conditions.
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
PH trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-11-05Distribution$910.19-3.7%Entry 24
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 3.7% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 7% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 32%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (24 analysts) rates it buy, with a mean price target of $1034. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-04Distribution$944.99+1.8%Entry 23
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 1.8% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 7% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 32%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (24 analysts) rates it buy, with a mean price target of $1034. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-03Distribution$928.29+3.2%Entry 22
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 3.2% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 7% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 32%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (24 analysts) rates it buy, with a mean price target of $1034. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-02Distribution$899.82+0.0%Entry 21
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 7% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 32%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (24 analysts) rates it buy, with a mean price target of $1034. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-01Distribution$899.82+0.0%Entry 20
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 7% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 32%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (24 analysts) rates it buy, with a mean price target of $1034. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-31Distribution$899.82-3.1%Entry 19
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 3.1% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 7% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 32%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (24 analysts) rates it buy, with a mean price target of $1034. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-30Distribution$928.45+1.8%Entry 18
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 1.8% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 7% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 32%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (24 analysts) rates it buy, with a mean price target of $1034. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-29Distribution$911.92-5.2%Entry 17
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 5.2% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 7% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 32%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (24 analysts) rates it buy, with a mean price target of $1034. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from accumulation to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 2% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 32%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (24 analysts) rates it buy, with a mean price target of $1034.
2026-10-18Accumulation$961.75-1.7%Entry 15
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 1.7% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 1% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 32%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (24 analysts) rates it buy, with a mean price target of $1034.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.